April 2016

ASCO Policy Statement on Clinical Pathways in Oncology: Why Now?

April 11, 2016

Evidence-Based Oncology

Members of the American Society of Clinical Oncology (ASCO) have articulated concerns regarding the current proliferation of clinical pathways in oncology that could affect patient access and care quality. In response, ASCO established an ad hoc Task Force, which issued a policy statement to guide the future development and implementation of these treatment management tools.

The Oncology Medical Home - Beyond Clinical Pathways

April 11, 2016

Evidence-Based Oncology

Clinical pathways have been emphasized as a means to deliver efficient, quality care and to ensure better outcomes at lower costs. The Oncology Medical Home takes this to the next, more comprehensive, step of quantifying and improving quality and value in cancer care while lowering overall costs.

Cancer Care Pathways: Hopes, Facts, and Concerns

April 13, 2016

Evidence-Based Oncology

Cancer pathways can potentially improve patient outcomes and reduce costs. Recent concerns about pathway adoption deserve attention, including excessive administrative burden to clinics.

Clinical Pathways: A Systems Approach Toward More Patient-Centric Cancer Care Delivery

April 16, 2016

Evidence-Based Oncology

Despite the fundamental advances in cancer care technology and care delivery that have made these improvements possible, our delivery system remains quite inefficient and frequently falls short of being truly patient-centered. Is a system-based solution the answer?

Are Oncology Clinical Pathways a Value Framework in the Making?

April 18, 2016

Evidence-Based Oncology

Evidence-Based Oncology invited a panel of experts who are experienced in the creation of oncology care pathways, use them in their practice, and have researched the development and implementation of care pathways, to exchange ideas on the topic.

Conference Coverage: ACCC

April 20, 2016

Evidence-Based Oncology

Coverage of sessions held at Cancerscape, the Association of Community Cancer Center’s 42nd annual meeting on policy, value, and quality, held March 2-4, 2016, in Washington, DC.